PHASE I/II TRIAL OF AN HSP90 INHIBITOR IN COMBINATION WITH AN MTOR INHIBITOR FOR PATIENTS WITH REFRACTORY MALIGNANT PERIPHERAL NERVE SHEATH TUMORS

$1,124,998FY2013Department of DefenseDOD

Sarc, Ann Arbor MI

Investigators